> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Nevro Sacroiliac Joint Fusion Device
- URL: https://www.fdaweb.com/fda-clears-nevro-sacroiliac-joint-fusion-device/
- Published: 2024-02-28T12:00:00.000Z
- Updated: 2026-09-14T14:24:06.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5156446

FDA has cleared a Nevro 510(k) for its Nevro1 sacroiliac (SI) joint fusion device for treating chronic SI joint pain. The company says the device is proven to “immediately transfix the SI joint to allow the opportunity for long-term fusion. Self-contained, deployable titanium anchors transfix the sacrum and ilium to enhance axial and rotational stability of the joint.” Additionally, Nevro says its proprietary instrumentation allows for “optimal intra-articular SI joint preparation,” which is key to achieve joint fusion. The device, it adds, includes 3D-printed, “bone-growth enhancing technology” which helps induce bone cell growth and fusion.